The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: a longitudinal study.
Open accessAbstract
Ayahuasca is an Amazonian psychoactive plant beverage containing the serotonergic 5-HT(2A) agonist N,N-dimethyltryptamine (DMT) and monoamine oxidase-inhibiting alkaloids (harmine, harmaline and tetrahydroharmine) that render it orally active. Ayahuasca ingestion is a central feature in several Brazilian syncretic churches that have expanded their activities to urban Brazil, Europe and North America. Members of these groups typically ingest ayahuasca at least twice per month. Prior research has shown that acute ayahuasca increases blood flow in prefrontal and temporal brain regions and that it elicits intense modifications in thought processes, perception and emotion. However, regular ayahuasca use does not seem to induce the pattern of addiction-related problems that characterize drugs of abuse. To study the impact of repeated ayahuasca use on general psychological well-being, mental health and cognition, here we assessed personality, psychopathology, life attitudes and neuropsychological performance in regular ayahuasca users (n = 127) and controls (n = 115) at baseline and 1 year later. Controls were actively participating in non-ayahuasca religions. Users showed higher Reward Dependence and Self-Transcendence and lower Harm Avoidance and Self-Directedness. They scored significantly lower on all psychopathology measures, showed better performance on the Stroop test, the Wisconsin Card Sorting Test and the Letter-Number Sequencing task from the WAIS-III, and better scores on the Frontal Systems Behavior Scale. Analysis of life attitudes showed higher scores on the Spiritual Orientation Inventory, the Purpose in Life Test and the Psychosocial Well-Being test. Despite the lower number of participants available at follow-up, overall differences with controls were maintained one year later. In conclusion, we found no evidence of psychological maladjustment, mental health deterioration or cognitive impairment in the ayahuasca-using group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been repeatedly found that ingestion of a psychedelic drug can induce rapid and persisting changes in personality traits, and particularly reductions in neuroticism, in both healthy and clinical populations (24, 35–41).”
From Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees (2022) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ayahuasca also displays potential mental health protection (Bouso et al., 2012; Grob et al., 1996; Halpern et al., 2008)”
From Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach (2018) · cites this paper as Bouso et al., 2012
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Bouso et al. (2012) found higher scores for spiritual orientation and purpose in life in ayahuasca users”
From Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach (2018) · cites this paper as Bouso et al. (2012)
The cited source says what the claim attributes to it.
In the citing paper
“Another study comparing personality traits between long-term ayahuasca users and non-users showed higher scores in the former of 'Self-transcendence' (Bouso et al., 2012)”
From Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach (2018) · cites this paper as Bouso et al., 2012
The cited source says what the claim attributes to it.
In the citing paper
“differences in life purpose and related variables in long-term ayahuasca users (Barbosa et al., 2016; Bouso et al., 2012).”
From Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach (2018) · cites this paper as Bouso et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Integrative Theory of Prefrontal Cortex Function
Miller, E. K., & Cohen, J. D. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.167 · Cited by 12,803
A compendium of neuropsychological tests: administration, norms, and commentary
(1991) · Choice Reviews Online · doi:10.5860/choice.29-2400 · Cited by 6,118
A psychobiological model of temperament and character
Cloninger, C. R. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820240059008 · Cited by 5,458
A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary
Levin, H. S. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540050007005 · Cited by 4,796
Wechsler Adult Intelligence Scale--Third Edition
Wechsler, D. (2019) · PsycTESTS Dataset · doi:10.1037/t49755-000 · Cited by 2,327
The temperament and character inventory (TCI) : a guide to its development and use
Cloninger, C. R. (1994) · Medical Entomology and Zoology · Cited by 2,319
Verdejo‐García, A., Lawrence, A. J., & Clark, L. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.11.003 · Cited by 1,502
Frontal–subcortical neuronal circuits and clinical neuropsychiatry
Tekin, S., & Cummings, J. L. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00428-2 · Cited by 1,240
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Stenner, K. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511614712 · Cited by 942
Flagged first, then by citations
Research works printed but not linked: 3
- [32]Bouso JC, Riba J (2011) An overview of the literature on the pharmacology and neuropsychiatric long term effects of ayahuasca. In: Santos R.G. (Ed.): The ethnopharmacology of ayahuasca. Kerala, India: Transworld Research Network. pp: 55–63. Ebook. Available: http://www.trnres.com/ebook/uploads/rafael/T_12998350813%20Rafael.pdf. Accessed: 2012 March 2.
- [35]Fuentes D, Tavares H, Camargo CHP, Gorenstein C (2000) Inventário de Temperamento e de Carácter de Cloninger – Validação da versão em Português. In: Escalas de Avaliação Clínica em Psiquiatria e Psicofarmacologia. pp. 363– 369.
- [46]Elkins DN, Hedstrom LJ, Hughes LL, Leaf JA, Saunders C (1988) Toward phenomenological spirituality: Definition, description, and measurement. J Humanist Psychol 28: 5– 18.
Cited by
Sorted by citations
Items 101–200 of 311
Fernández, X., dos Santos, R. G., Cutchet, M., Fondevila, S., González, D., Alcázar, M. Á., Riba, J., Bouso, J. C., & María Fábregas, J. (2014) · The Therapeutic Use of Ayahuasca · doi:10.1007/978-3-642-40426-9_11 · Cited by 36
Self-citationWinkler, P., & Csémy, L. (2014) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2013.873158 · Cited by 39
Stability Evaluation of DMT and Harmala Alkaloids in Ayahuasca Tea Samples
Silveira, G. D. O., SANTOS, R. G. D., Lourenço, F. R., Rossi, G. N., Hallak, J. E. C., & Yonamine, M. (2020) · Molecules · doi:10.3390/molecules25092072 · Cited by 37
Is Ayahuasca an Option for the Treatment of Crack Cocaine Dependence?
da Cruz, J. I., & Nappo, S. A. (2018) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2018.1447174 · Cited by 36
Gard, D. E., Pleet, M. M., Bradley, E., Penn, A., Gallenstein, M. L., Riley, L. S., DellaCrosse, M. A., Garfinkle, E. M., Michalak, E. E., & Woolley, J. D. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100240 · Cited by 37
Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats
Favaro, V. M., Yonamine, M., Soares, J. C. K., & Oliveira, M. G. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145840 · Cited by 36
Egger, K., Aicher, H., Cumming, P. D., & Scheidegger, M. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05353-6 · Cited by 37
Nootropic effects of LSD: Behavioral, molecular and computational evidence
Ornelas, I. M., da Silva, F. A. C., Wießner, I., Marcos, E., de Araújo, D. B., Goto‐Silva, L., Nascimento, J. M., Silva, S. R. B., Costa, M., Falchi-Carvalho, M., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114148 · Cited by 37
A Qualitative Study of Intention and Impact of Ayahuasca Use by Westerners
Bathje, G. J., Fenton, J., Pillersdorf, D., & Hill, L. C. (2021) · Journal of Humanistic Psychology · doi:10.1177/00221678211008331 · Cited by 34
Ayahuasca, a psychedelic beverage, modulates neuroplasticity induced by ethanol in mice
Almeida, C. A. D. F., Pereira-Júnior, A. A., Rangel, J. G., Pereira, B. P., Costa, K. C. M., Bruno, V., Silveira, G. D. O., Ceron, C. S., Yonamine, M., Camarini, R., et al. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113546 · Cited by 35
Rossi, G. N., Guerra, L. T. L., Baker, G. B., Dursun, S. M., Bouso, J. C., Hallak, J. E. C., & SANTOS, R. G. D. (2022) · Biomolecules · doi:10.3390/biom12111618 · Cited by 33
Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine
O’Shaughnessy, D. M., Berlowitz, I., Rodd, R., Sarnyai, Z., & Quirk, F. H. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320986634 · Cited by 32
Barnett, B. S., Arakelian, M. H., Beebe, D. S., Ontko, J., Riegal, C., Siu, W. O., Weleff, J., & Pope, H. G. (2023) · Psychedelic Medicine · doi:10.1089/psymed.2023.0036 · Cited by 31
Kaasik, H., & Kreegipuu, K. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1748773 · Cited by 37
Analysis of recreational psychedelic substance use experiences classified by substance
Hase, A., Erdmann, M., Limbach, V., & Hasler, G. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06062-3 · Cited by 33
Johnstad, P. G. (2021) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1842569 · Cited by 29
Rush, B. R., Marcus, O., García, S., Loizaga-Velder, A. K., Loewinger, G. C., Spitalier, A., & Mendive, F. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.659644 · Cited by 32
Oña, G., Berrada, A., & Bouso, J. C. (2021) · Transcultural Psychiatry · doi:10.1177/13634615211038416 · Cited by 32
Perkins, D., Ruffell, S., Day, K., Rubiano, D. P., & Sarris, J. J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.879221 · Cited by 33
Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?
Malcolm, B., & Lee, K. C. (2017) · Mental Health Clinician · doi:10.9740/mhc.2017.01.039 · Cited by 34
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy
Orsolini, L., Chiappini, S., Papanti, D., Latini, R., Volpe, U., Fornaro, M., Tomasetti, C., Vellante, F., & Berardis, D. D. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2728 · Cited by 33
When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research
Jacobs, E., Murphy-Beiner, A., Rouiller, I., Nutt, D. J., & Spriggs, M. J. (2023) · Neuroethics · doi:10.1007/s12152-023-09536-z · Cited by 31
Kiraga, M. K., Kuypers, K. P. C., Uthaug, M. V., Ramaekers, J. G., & Mason, N. L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.883869 · Cited by 26
“It has been repeatedly found that ingestion of a psychedelic drug can induce rapid and persisting changes in personality traits, and particularly reductions in neuroticism, in both healthy and clinical populations (Barrett et al. 2020; Bouso et al. 2012; Bouso et al. 2015; Erritzoe et al. 2018; Johnstad 2021; Kiraga e…”
BackgroundTeacher plants — Indigenous Peruvian-Amazonian dietary practices as a method for using psychoactives
Berlowitz, I., O’Shaughnessy, D. M., Heinrich, M., Wolf, U., Maake, C., & Martin-Söelch, C. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114910 · Cited by 31
Kohek, M., Ona, G., van Elk, M., Dos Santos, R. G., Hallak, J. E. C., Alcázar-Córcoles, M. Á., & Bouso, J. C. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2077155 · Cited by 24
Politi, M., Tresca, G., Menghini, L., & Ferrante, C. (2021) · Planta Medica · doi:10.1055/a-1675-3840 · Cited by 25
The link between use of psychedelic drugs and mental health problems
Nesvåg, R., Bramness, J. G., & Ystrøm, E. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115596156 · Cited by 23
Colaço, C. S., Alves, S. S., Nolli, L. M., Pinheiro, W. O., de Oliveira, D. G. R., Santos, B. W. L., Taylor, A. P., Mortari, M. R., & Caldas, E. D. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00854-w · Cited by 23
Personality Traits in Former Spanish Substance Users Recovered with Ayahuasca
Apud Peláez, I. E. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1752960 · Cited by 22
Amazonian Medicine and the Psychedelic Revival: Considering the “Dieta”
O’Shaughnessy, D. M., & Berlowitz, I. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.639124 · Cited by 22
The illusion of knowledge in the emerging field of psychedelic research
Oña, G., Kohek, M., & Bouso, J. C. (2022) · New Ideas in Psychology · doi:10.1016/j.newideapsych.2022.100967 · Cited by 24
Gomes, M. M., Coimbra, J. B., Clara, R. O., Dörr, F. A., Moreno, A. C. R., Chagas, J. R., Tufik, S., Pinto, E., Catalani, L. H., & Čampa, A. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.035 · Cited by 22
Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland
Kangaslampi, S., Hausen, A., & Rauteenmaa, T. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1767321 · Cited by 31
An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice
Correa-Netto, N. F., Masukawa, M. Y., Nishide, F., Galfano, G. S., Tamura, F., Shimizo, M. K., Marcato, M. P., Santos-Junior, J. G., & Linardi, A. (2017) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20176036 · Cited by 21
Can Psychedelic Drugs Attenuate Age-Related Changes in Cognition and Affect?
Aday, J. S., Bloesch, E. K., & Davoli, C. C. (2019) · Journal of Cognitive Enhancement · doi:10.1007/s41465-019-00151-6 · Cited by 23
Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability
Rossi, G. N., Dias, I. C. D. S., Baker, G. B., Bouso, J. C., Dursun, S. M., Hallak, J. E. C., & SANTOS, R. G. D. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2054988 · Cited by 23
Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20thCentury
Aday, J. S., Bloesch, E. K., & Davoli, C. C. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1581961 · Cited by 19
The current state of ayahuasca research in animal models: A systematic review
Daldegan‐Bueno, D., Simionato, N. M., Favaro, V. M., & Maia, L. O. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110738 · Cited by 21
Perkins, D., Opaleye, E. S., Bouso, J. C., Tófoli, L. F., Sarris, J. J., Schubert, V., Ruffell, S., & Šimonová, H. (2023) · Psychoactives · doi:10.3390/psychoactives2040017 · Cited by 21
Basedow, L. A., Majić, T., Hafiz, N. J., Algharably, E. A. E., Kreutz, R. H., & Riemer, T. (2024) · Scientific Reports · doi:10.1038/s41598-024-65391-9 · Cited by 19
Scheidegger, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_3 · Cited by 21
Immunological Effects of Ayahuasca in Humans
SANTOS, R. G. D. (2014) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2014.960113 · Cited by 18
Liester, M. B. (2013) · The Journal of transpersonal psychology · Cited by 18
de Camargo, R. W., Joaquim, L. D. S., Machado, R. S., Ramos, S. D. S., da Rosa, L. R., Júnior, L. R. D. N., Mathias, K., Maximiano, L., Strickert, Y. R., Nord, R., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04597-4 · Cited by 18
Basedow, L. A., Riemer, T., Reiche, S., Kreutz, R. H., & Majić, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.739966 · Cited by 17
Vorobyeva, N. S., & Kozlova, A. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.927984 · Cited by 20
Ayahuasca: what mental health professionals need to know
dos Santos, R. D., Bouso, J., & Hallak, J. (2017) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/0101-60830000000130 · Cited by 12
van Oorsouw, K. I. M., Uthaug, M. V., Mason, N. L., Broers, N. J., & Ramaekers, J. G. (2021) · Journal of Psychedelic Studies · doi:10.1556/2054.2021.00174 · Cited by 17
It’s Tea Time: Interference of Ayahuasca Brew on Discriminative Learning in Zebrafish
Soares, B. L., Eduardo-da-Silva, P., Amarilha, H., Pinheiro‐da‐Silva, J., Silva, P. F., & Luchiari, A. C. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00190 · Cited by 17
Aixalà, M., Oña, G., Parés, Ò., & Bouso, J. C. (2019) · Drugs Education Prevention and Policy · doi:10.1080/09687637.2019.1611739 · Cited by 18
Utilizing Psychedelics to Enhance Well-Being: A Systematic Review
Thomson, S., & Thomacos, N. (2025) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2025.2484380 · Cited by 16
Weiss, B., Sleep, C. E., Beller, N. M., Erritzøe, D., & Campbell, W. K. (2023) · Journal of Psychedelic Studies · doi:10.1556/2054.2023.00291 · Cited by 15
Ayahuasca: Pharmacology, Safety, and Therapeutic Effects
SANTOS, R. G. D., & Hallak, J. E. C. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009585330.005 · Cited by 20
Oña, G., & Bouso, J. C. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191212103330 · Cited by 18
Effect of Ritualistic Consumption of Ayahuasca on Hepatic Function in Chronic Users
Mello, S. M., Soubhia, P. C., Silveira, G. D. O., Correa-Netto, N. F., Lanaro, R., Costa, J. L., & Linardi, A. (2018) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2018.1557355 · Cited by 19
van den Berg, M., Magaraggia, I., Schreiber, R., Hillhouse, T. M., & Porter, J. H. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06106-8 · Cited by 13
Apud, I., Scuro, J., Carrera, I., & Oliveri, A. (2022) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2053004 · Cited by 14
Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers
Rossi, G. N., Rocha, J. M., Osório, F. D. L., Bouso, J. C., Oña, G., Silveira, G. D. O., Yonamine, M., Bertozi, G., Crevelin, E. J., Queiroz, M. E. C., et al. (2023) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001691 · Cited by 14
Fonseca, A. M., SANTOS, R. G. D., de Medeiros, L. S., Veiga, T. A. M., Cassas, F., Bruniera, C. P., Rossi, G. N., Bouso, J. C., Hallak, J. E. C., Santos, F. P., et al. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01817-9 · Cited by 13
Being for no-one: Psychedelic experience and minimal subjectivity
Letheby, C. (2020) · Philosophy and the Mind Sciences · doi:10.33735/phimisci.2020.i.47 · Cited by 20
Prophylactic action of ayahuasca in a non-human primate model of depressive-like behavior
Grilo, M. L. P. D. M., de Sousa, G. M., de Mendonça, L. A. C., Soares, B. L., de Sousa, M. B. C., Palhano-Fontes, F., de Araújo, D. B., Perkins, D., Hallak, J. E. C., & Coelho, N. L. G. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.901425 · Cited by 16
NATURAL PSYCHODYSLEPTIC COMPOUNDS: SOURCES AND PHARMACOLOGY
Padavala, S., & Ezhilarasan, D. (2016) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2016.v9i5.13345 · Cited by 11
Psicosis inducida por ayahuasca: reporte de un caso.
Neyra-Ontaneda, D. (2017) · Revista de Neuro-Psiquiatría · doi:10.20453/rnp.v80i4.3241 · Cited by 11
Lanaro, R., Mello, S. M., da Cunha, K. F., Silveira, G. D. O., Correa-Netto, N. F., Hyslop, S., Cabrices, O. G., Costa, J. L., & Linardi, A. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2955 · Cited by 11
Lowe, M. X., Kettner, H., Jolly, D. R. P., Carhart-Harris, R. L., & Jackson, H. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1279887 · Cited by 14
Sayin, H. U. (2014) · Cited by 10
The Spiritual Orientation Inventory (SOI): A Multidimensional Measure of Humanistic Spirituality
Lazar, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-52140-0_11 · Cited by 10
Can Ayahuasca and sleep loss change sexual performance in male rats?
Alvarenga, T. A., Polesel, D. N., Matos, G., Garcia, V. A., Costa, J. L., Tufik, S., & Andersen, M. L. (2014) · Behavioural Processes · doi:10.1016/j.beproc.2014.09.024 · Cited by 10
Chronic intermittent exposure to ayahuasca during aging does not affect memory in mice
Correa-Netto, N. F., Coelho, L. S., Galfano, G. S., Nishide, F., Tamura, F., Shimizu, M. K., Santos-Junior, J. G., & Linardi, A. (2017) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20176037 · Cited by 10
Hallucinations and Hallucinogens: Psychopathology or Wisdom?
Bouso, J. C., Oña, G., Kohek, M., SANTOS, R. G. D., Hallak, J. E. C., Alcázar‐Córcoles, M. Á., & Obiols‐Llandrich, J. (2023) · Culture Medicine and Psychiatry · doi:10.1007/s11013-022-09814-0 · Cited by 15
Childhood trauma, challenging experiences, and posttraumatic growth in ayahuasca use
Cassidy, E. K., Healy, C. J., Henje, E., & D'Andrea, W. M. (2024) · Drug Science Policy and Law · doi:10.1177/20503245241238316 · Cited by 9
Ayahuasca Treatment Center Safety for the Western Seeker
Ray, R. R., & Lassiter, K. S. (2016) · Anthropology of Consciousness · doi:10.1111/anoc.12060 · Cited by 9
Bouso, J. C., Révész, D., Oña, G., Rossi, G. N., Rocha, J. M., SANTOS, R. G. D., Hallak, J. E. C., & Alcázar‐Córcoles, M. Á. (2023) · Scientific Reports · doi:10.1038/s41598-023-41199-x · Cited by 9
Determination of the Elemental Composition of Ayahuasca and Assessments Concerning Consumer Safety
Guimarães, I. C., Tófoli, L. F., & Sussulini, A. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02226-4 · Cited by 9
Zkušenost s halucinogenní rostlinou ayahuasca v kontextu šamanského rituálu
Kavenská, V., & Šimonová, H. (2014) · Anthropologia integra · doi:10.5817/ai2014-1-51 · Cited by 9
Hovmand, O. R., Madsen, M. K., Fisher, P. M., & Stenbæk, D. S. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241269669 · Cited by 9
Godfrey, K. E. M., Weiss, B., Zhang, X., Spriggs, M. J., Peill, J. M., Lyons, T., Carhart-Harris, R. L., & Erritzøe, D. (2024) · Neuroscience Applied · doi:10.1016/j.nsa.2024.104092 · Cited by 10
Świeczkowski, D., Kwaśny, A., & Cubała, W. J. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111419 · Cited by 8
Olofsson, M., Osika, W., Goldberg, S. B., Hendricks, P. S., Petrović, P., White, T. J. H., Stenfors, C. U. D., Chaturvedi, S., & Simonsson, O. (2025) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2025.105105 · Cited by 10
Psychedelics and psychological strengths
Brasher, T. J., Rosen, D., & Spinella, M. (2023) · International Journal of Wellbeing · doi:10.5502/ijw.v13i1.2325 · Cited by 10
Cortical structural differences following repeated ayahuasca use hold molecular signatures
Mallaroni, P., Mason, N. L., Kloft, L., Reckweg, J. T., van Oorsouw, K. I. M., & Ramaekers, J. G. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1217079 · Cited by 8
Stenbæk, D. S., Kristiansen, S., Burmester, D., Madsen, M. K., Frokjaer, V. G., Knudsen, G. M., & Fisher, P. M. (2019) · Human Brain Mapping · doi:10.1002/hbm.24511 · Cited by 11
Episodios psicóticos inducidos por ayahuasca: revisión sistemática a partir de un caso.
Alcantarilla, L., García-Alcarria, E., & Almonacid, C. (2022) · Revista de Neuro-Psiquiatría · doi:10.20453/rnp.v85i3.4331 · Cited by 9
Perkins, D., Sarris, J. J., Cowley‐Court, T., Aicher, H., Tófoli, L. F., Bouso, J. C., Opaleye, E. S., Halman, A., Coelho, N. L. G., & Schubert, V. (2024) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2024.2424288 · Cited by 7
Doss, M. K., Kloft, L., Mason, N. L., Mallaroni, P., Reckweg, J. T., van Oorsouw, K. I. M., Tupper, N., Otgaar, H., & Ramaekers, J. G. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241301216 · Cited by 8
Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption
Pagni, B. A., Halman, A., Sarris, J. J., Chenhall, R. D., Bogenschutz, M. P., & Perkins, D. (2025) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2025.2465800 · Cited by 7
Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis
Reiche, S., Hirschfeld, T., Gröticke, A., Traub, M., Hafiz, N. J., Haas, R., Sedlaczek, L., Ortlieb, L., Leistenschneider, G., Basedow, L. A., et al. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111353 · Cited by 7
Therapeutic Use of Hallucinogens
Wiltenburg, V. D., Prado, D. D. R., & Mendes, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-62855-0_35 · Cited by 1
Khubsing, R. S. I., van Leerdam, M., Haijen, E. C. H. M., & Kuypers, K. P. C. (2024) · Psychoactives · doi:10.3390/psychoactives3020011 · Cited by 6
OAV and 5D-ASC for Brazilian Portuguese: A validation and adaptation study
Rodrigues, R., Wießner, I., Daldegan‐Bueno, D., Bienemann, B., Pontual, A. A. D. D., Tófoli, L. F., & Mograbi, D. C. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251344685 · Cited by 6
Use of Herbal Medicine to Treat Drug Addiction
Mendes, F. R., & Prado, D. D. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-43172-7_4 · Cited by 6
Psychedelic therapy in the Czech Republic: A theoretical concept or a realistic goal?
Postránecká, Z., Vejmola, Č., & Tylš, F. (2019) · Journal of Psychedelic Studies · doi:10.1556/2054.2019.003 · Cited by 7
López‐Arnau, R., Camarasa, J., Carbó, M., Nadal‐Gratacós, N., Puigseslloses, P., Espinosa‐Velasco, M., Urquizu, E., Escubedo, E., & Pubill, D. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.990405 · Cited by 6
Preliminary evidence of links between ayahuasca use and the corpus callosum
Simonsson, O., Bouso, J. C., Kurth, F., de Araújo, D. B., Gaser, C., Riba, J., & Eileen Luders, A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1002455 · Cited by 6
Hovmand, O. R., Jensen, M. E., Juul, T. S., Madsen, M. K., Fisher, P. M., & Stenbæk, D. S. (2024) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2024.2302186 · Cited by 6
Johnstad, P. G. (2015) · Nordic Studies on Alcohol and Drugs · doi:10.1515/nsad-2015-0053 · Cited by 11
Ayahuasca: el encuentro de dos paradigmas.
Rojas-Bolívar, D. (2014) · Revista de Neuro-Psiquiatría · doi:10.20453/rnp.v77i1.1162 · Cited by 7
Increases in Aesthetic Experience Following Ayahuasca Use: A Prospective, Naturalistic Study
Aday, J. S., Bloesch, E. K., Davis, A. K., Domoff, S. E., Scherr, K. C., Woolley, J. D., & Davoli, C. C. (2024) · Journal of Humanistic Psychology · doi:10.1177/00221678241230609 · Cited by 7
The Therapeutic Effects of Classic Psychedelics in Alcohol Use Disorder
Pagni, B. A., Wong, J. M., & Bogenschutz, M. P. (2024) · Current Addiction Reports · doi:10.1007/s40429-024-00581-z · Cited by 6
Levin, A. W. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241303599 · Cited by 5
Metadata
- Authors
- Bouso, J. C., González, D., Fondevila, S., Cutchet, M., Fernández, X., Ribeiro Barbosa, P. C., Alcázar-Córcoles, M. Á., Araújo, W. S., Barbanoj, M. J., Fábregas, J. M., & Riba, J.
- Affiliations
- Universitat Autònoma de Barcelona (ES)
- Instituto de Salud Carlos III (ES)
- Corresponding author
- Bouso, José Carlos
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-08-08
- Volume
- 7
- Issue
- 8
- Pages
- e42421
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3414465
- OpenAlex
- W2100834566
- Cited by
- 313
- References
- 67
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 31 · 2023: 30 · 2022: 38 · 2021: 32 · 2020: 31 · 2019: 16 · 2018: 21 · 2017: 14 · 2016: 20 · 2015: 23 · 2014: 15 · 2013: 6
- FWCI
- 15.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion)
- Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) (publishedVersion)
- Biblos-e Archivo (Universidad Autónoma de Madrid) (submittedVersion, public-domain)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Hispana (submittedVersion, other-oa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Keywords
- ayahuasca, ritual drug use, personality, psychopathology, life attitude, neuropsychological performance, cognitive function, psychological well-being, harm avoidance, reward dependence, self-transcendence, self-direction, Stroop task, Wisconsin Card Sorting Test, Frontal Systems Behavior Scale, spiritual orientation, meaning of life, psychosocial well-being
- MeSH terms
- Adult, Attitude, Brazil, Cerebrovascular Circulation, Ceremonial Behavior, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Mental Health, Middle Aged, Neuropsychological Tests, Neuropsychology, Personality, Psychopathology, Reward, Case-Control Studies, Banisteriopsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
